Oncolytic Virus Therapies Market Report 2033
Oncolytic virus therapies represent a type of immunotherapy that harnesses viruses to selectively infect and destroy cancer cells. These therapies utilize a range of natural and genetically modified viruses, including herpes simplex, Newcastle disease virus, vaccinia virus, adenovirus, reovirus, and picornavirus. By activating danger signals in the body, oncolytic virus therapies generate an immune response, making them particularly effective for treating solid tumors, melanoma, and unresectable lesions.
https://www.imarcgroup.com...
Oncolytic virus therapies represent a type of immunotherapy that harnesses viruses to selectively infect and destroy cancer cells. These therapies utilize a range of natural and genetically modified viruses, including herpes simplex, Newcastle disease virus, vaccinia virus, adenovirus, reovirus, and picornavirus. By activating danger signals in the body, oncolytic virus therapies generate an immune response, making them particularly effective for treating solid tumors, melanoma, and unresectable lesions.
https://www.imarcgroup.com...
10:51 AM - Jan 09, 2025 (UTC)
No replys yet!
It seems that this publication does not yet have any comments. In order to respond to this publication from vishalguptaimarc , click on at the bottom under it
Who to follow